UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

Respiratory research, 2019-08, Vol.20 (1), p.180-180, Article 180

2019

Volltextzugriff (PDF)

Peregrine Horden – Nicholas Purcell, “The Boundless Sea”

Storicamente, 2022, Vol.18 (2022)

Geraci, Silvia

2022

Volltextzugriff (PDF)

Use of the Bruininks-Oseretsky test of motor proficiency (BOT-2) to assess efficacy of velmanase alfa as enzyme therapy for alpha-mannosidosis

Molecular genetics and metabolism reports, 2020-06, Vol.23, p.100586-100586, Article 100586

2020

Volltextzugriff (PDF)

Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis

Journal of inborn errors of metabolism and screening, 2018-09, Vol.6

2018

Volltextzugriff (PDF)

Musculoskeletal Pain as a Novel Complication After Posterior Tibial Nerve Block in Stroke and Traumatic Brain Injury Patients

PM & R, 2011-05, Vol.3 (5), p.492-494

2011

Volltextzugriff (PDF)

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Advances in therapy, 2019-02, Vol.36 (2), p.462-477

2019

Volltextzugriff (PDF)

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe

Transplant international, 2022-03, Vol.35, p.10225-10225

2022

Volltextzugriff (PDF)

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial

Journal of inherited metabolic disease, 2018-12, Vol.41 (6), p.1215-1223

2018

Volltextzugriff (PDF)

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis

Journal of inherited metabolic disease, 2018-11, Vol.41 (6), p.1225-1233

2018

Volltextzugriff (PDF)

Global treatment response analysis of velmanase alfa long term enzyme replacement therapy for alpha-mannosidosis shows treatment benefit across ages

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S58-S58

2018

Volltextzugriff (PDF)

Gender, mutations and residual enzymatic activity: Investigation of predictive factors of alpha-mannosidosis phenotypic presentation and of response to velmanase alfa long term enzyme replacement therapy

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S35-S36

2018

Volltextzugriff (PDF)

Global treatment responder analysis demonstrates clinically relevant effect of velmanase alfa long term enzyme replacement therapy for alpha mannosidosis, in a phase III randomized placebo controlled trial

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S58-S58

2018

Volltextzugriff (PDF)

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Advances in therapy, 2019-02, Vol.36 (2), p.462-477

2019

Volltextzugriff (PDF)

Long-term enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase) improves mobility in alpha-mannosidosis patients

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S88-S89

2017

Volltextzugriff (PDF)

Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis: Long-Term Data of Enzyme Replacement Therapy With Velmanase Alfa (Human Recombinant Alpha Mannosidase)

Journal of inborn errors of metabolism and screening, 2018-09, Vol.6, p.232640981879685

2018

Volltextzugriff (PDF)

Messianicité structurelle et temps messianique: Entre révélabilité et révélation

Les Cahiers philosophiques de Strasbourg, 2015-05 (37), p.87-108

Geraci, Silvia

2015

Volltextzugriff (PDF)

Messianicité structurelle et temps messianique

Les Cahiers philosophiques de Strasbourg, 2015, p.87-108

Geraci, Silvia

2015

Volltextzugriff (PDF)

JACQUES DERRIDA AND ABRAHAM'S HERITAGE

Bijdragen tijdschrift voor filosofie en theologie, 2011-01, Vol.72 (3), p.246-264

GERACI, SILVIA

2011

Volltextzugriff (PDF)

Messianisme, souveraineté et sécularisation

Les Cahiers philosophiques de Strasbourg, 2015

2015

Volltextzugriff (PDF)

Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stenting

Giornale italiano di cardiologia, 1998-12, Vol.28 (12), p.1345

1998

Volltextzugriff (PDF)

Evaluations of pro-environmental behaviors by 7-month-old infants

Infant behavior & development, 2023-08, Vol.72, p.101865, Article 101865

2023

Volltextzugriff (PDF)

Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome

PloS one, 2016-09, Vol.11 (9), p.e0162490

2016

Volltextzugriff (PDF)

Substantial discrepancies exist between registered protocol and published manuscript in trials on exercise interventions for chronic low back pain: a metaresearch study

Journal of clinical epidemiology, 2024-09, Vol.173, p.111465, Article 111465

2024

Volltextzugriff (PDF)

Risk of SARS-CoV-2 infection in migrants and ethnic minorities compared with the general population in the European WHO region during the first year of the pandemic: a systematic review

BMC public health, 2022-01, Vol.22 (1), p.143-143, Article 143

2022

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(46)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

Peregrine Horden – Nicholas Purcell, “The Boundless Sea”

Use of the Bruininks-Oseretsky test of motor proficiency (BOT-2) to assess efficacy of velmanase alfa as enzyme therapy for alpha-mannosidosis

Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis

Musculoskeletal Pain as a Novel Complication After Posterior Tibial Nerve Block in Stroke and Traumatic Brain Injury Patients

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis

Global treatment response analysis of velmanase alfa long term enzyme replacement therapy for alpha-mannosidosis shows treatment benefit across ages

Gender, mutations and residual enzymatic activity: Investigation of predictive factors of alpha-mannosidosis phenotypic presentation and of response to velmanase alfa long term enzyme replacement therapy

Global treatment responder analysis demonstrates clinically relevant effect of velmanase alfa long term enzyme replacement therapy for alpha mannosidosis, in a phase III randomized placebo controlled trial

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Improvement in pulmonary function and serum immunoglobulin G in long-term enzyme replacement therapy with velmanase alfa(human recombinant alpha-mannosidase) in alpha-mannosidosis patients

Long-term enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase) improves mobility in alpha-mannosidosis patients

Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis: Long-Term Data of Enzyme Replacement Therapy With Velmanase Alfa (Human Recombinant Alpha Mannosidase)

Messianicité structurelle et temps messianique: Entre révélabilité et révélation

Messianicité structurelle et temps messianique

JACQUES DERRIDA AND ABRAHAM'S HERITAGE

Messianisme, souveraineté et sécularisation

Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stenting

Evaluations of pro-environmental behaviors by 7-month-old infants

Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome

Substantial discrepancies exist between registered protocol and published manuscript in trials on exercise interventions for chronic low back pain: a metaresearch study

Risk of SARS-CoV-2 infection in migrants and ethnic minorities compared with the general population in the European WHO region during the first year of the pandemic: a systematic review

Suchergebnisse filtern